Table 4.
Figure | Panel | Between treatment (MS) | Within treatment (MS) | dfn,dfd | F | p | Comparison | p |
---|---|---|---|---|---|---|---|---|
5 | F | 2123 | 279.6 | 3,23 | 7.592 | 0.0011 | SNI/veh versus Sham/veh | 0.0088 |
SNI/veh versus Sham/GP | 0.0047 | |||||||
SNI/veh versus SNI/GP | 0.0006 | |||||||
5 | G | 1753 | 384.7 | 5,34 | 4.557 | 0.0027 | SNI/veh versus Sham/veh | 0.0382 |
SNI/veh versus Sham/met | 0.0356 | |||||||
SNI/veh versus SNI/met 1d | 0.8067 | |||||||
SNI/veh 1d versus SNI/veh 14d | >0.9999 | |||||||
SNI/veh 1d versus SNI/met 14 | >0.9999 |
aveh, Vehicle; GP, gabapentin; met, metformin.